Can-Fite BioPharma Ltd. Royalty Expense
Can-Fite BioPharma Ltd. (CANF) reported Royalty Expense of EUR 10.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-03-26
| Period end | Royalty Expense 6 month | Royalty Expense 12 month |
|---|---|---|
| 2025-12-31 | 10.00K EUR 20-F · filed 2026-03-26 | |
| 2025-06-30 | 10.00K EUR 6-K · filed 2025-08-28 | |
| 2024-12-31 | 10.00K EUR 20-F · filed 2025-04-14 | |
| 2024-06-30 | 10.00K EUR 6-K · filed 2024-08-29 | |
| 2023-12-31 | 10.00K EUR 20-F · filed 2024-03-28 | |
| 2022-12-31 | 10.00K EUR 20-F · filed 2023-03-30 | |
| 2021-12-31 | 10.00K EUR 20-F · filed 2022-03-24 | |
| 2020-12-31 | 10.00K EUR 20-F · filed 2021-03-25 |